Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 21, 2008; 14(23): 3750-3753
Published online Jun 21, 2008. doi: 10.3748/wjg.14.3750
Published online Jun 21, 2008. doi: 10.3748/wjg.14.3750
Table 1 Characteristics of patients (n = 104)
| Characteristics | Data, n (%) |
| Age (yr) | 59 ± 9 (mean ± SD) |
| Sex | |
| Male | 72 (69.2) |
| Female | 32 (30.8) |
| Location of tumors | |
| Head | 86 (82.7) |
| Body | 8 (7.7) |
| Body and tail | 10 (9.6) |
| Type of operation | |
| Pancreaticoduodenectomy | 48 (46.2) |
| Distal pancreatectomy | 10 (9.6) |
| Exploratory laparotomy and biopsy | 46 (44.2) |
Table 2 CA19-9 levels in patients with resectable and unresectable pancreatic cancer
| Group | n | CA19-9 (U/mL) | Wilcoxon | |||
| Q1 | Q2 | Q3 | Z | P | ||
| Resectable | 58 | 15.57 | 130.10 | 270.25 | -5.132 | 0.000 |
| Unresectable | 46 | 361.30 | 656.20 | 1780.00 | ||
Table 3 Positive and negative predictive values of CA19-9 at the cut-off point
| Resection | Total | Predictive value | |||
| Yes | No | ||||
| CA19-9 (U/mL) | ≤ 353.15 | 54 | 10 | 64 | 84.38% (+) |
| > 353.15 | 4 | 36 | 40 | 90.00% (-) | |
| Total | 58 | 46 | 104 | ||
- Citation: Zhang S, Wang YM, Sun CD, Lu Y, Wu LQ. Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma. World J Gastroenterol 2008; 14(23): 3750-3753
- URL: https://www.wjgnet.com/1007-9327/full/v14/i23/3750.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3750